Validating Migraine‐Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Objective.— To provide evidence for the reliability and validity of the Migraine‐Specific Quality of Life Questionnaire Version 2.1 (MSQ) for use in chronic migraine (CM) in adults. Background.— MSQ is one of the most frequently utilized disease‐specific tools assessing impact of migraine on health‐related quality of life (HRQL). However, evidence for its reliability and validity are based on studies in episodic migraine (EM) populations. Additional studies assessing the reliability and validity of the MSQ in patients with CM are needed. Methods.— Cross‐sectional data were collected via web‐based survey in 9 countries/regions. Participants were classified as having CM (≥15 headache days/month) or EM (<15 headache days/month). Three MSQ domains – Role Function‐Preventive (RP), Role Function‐Restrictive (RR), and Emotional Function (EF) – were rescaled to 0‐100, where higher scores indicate better HRQL, and analyzed for internal consistency reliability (Cronbach's α), construct validity (correlations between MSQ scales and measures of depression/anxiety [Patient Health Questionnaire; PHQ‐4], disability [Migraine Disability Assessment Questionnaire; MIDAS], and functional impact [Headache Impact Test; HIT‐6], where lower scores indicate better HRQL for each measure), as well as discriminant validity across migraine groups. Results.— A total of 8726 eligible respondents were classified: 5.7% CM (n = 499) and 94.3% EM (n = 8227). Subjects were mostly female (83.5%) with a mean (±SD) age of 40.3 ± 11.4, and were similar between the 2 groups. MSQ domain scores for CM and EM groups, respectively, were: RP = 61.4 ± 26.1 and 71.7 ± 24.0; RR = 44.4 ± 22.1 and 56.5 ± 24.1; EF = 48.3 ± 28.1 and 67.2 ± 26.7. Internal consistency of the overall sample for RP, RR, and EF was 0.90, 0.96, and 0.87, respectively. Similar values were observed for CM and EM. MSQ scores for the overall sample correlated moderately to highly with scores from the PHQ‐4 ( r = −0.21 to −0.42), MIDAS ( r = −0.38 to −0.39), and HIT‐6 ( r = −0.60 to −0.71). Similar values were observed for CM and EM. Known‐groups validity indicated significant differences ( P < .0001) in the hypothesized direction between CM and EM for RP ( F = 86.19), RR ( F = 119.24), and EF ( F = 235.90). Conclusion.— The MSQ is a reliable and valid questionnaire in the CM population that can differentiate the functional impact between CM and EM. The MSQ can assist researchers in evaluating treatment effectiveness by obtaining input directly from the patients on multidimensional aspects other than frequency of headache days. ( Headache 2012;52:409‐421)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Foundations of Behavioral Research
Stockton, R., & Kerlinger, F. N. (1974) · American Educational Research Journal · doi:10.2307/1162206 · Cited by 7,347
The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000093487.78664.3c · Cited by 6,359
The International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,049
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · cited 1×
“Major depressive disorder scores 3 have demonstrated sensitivity of 83% and specificity of 90%,(41) while similar scores on the generalized anxiety disorder items demonstrated good sensitivity (86%) and good specificity (83%) for identifying patients with depression.(42) Recent studies have confirmed the reliability a…”
BackgroundAn Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
Measuring Health-Related Quality of Life
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00009 · Cited by 3,958
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298
Löwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.019 · Cited by 2,473 · cited 1×
“Recent studies have confirmed the reliability and validity of the PHQ-4 as a measure of depression and anxiety using a representative sample of the German general population.(43) Statistical Analysis.”
MethodMigraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
A six-item short-form survey for measuring headache impact: The HIT-6™
Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., Cady, R., Dahlöf, C. G. H., Dowson, A., & Tepper, S. (2003) · Quality of Life Research · doi:10.1023/a:1026119331193 · Cited by 1,376 · cited 1×
“Six domains are represented by the HIT-6: pain, role functioning, social functioning, energy or fatigue, cognition, and emotional distress.(32) Responses are provided on a 5-point scale in the categories “never,” “rarely,” “sometimes,” “very often,” and “always,” and are assigned values of 6, 8, 10, 11,”
BackgroundSelf-citationStewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210 · cited 4×
“MIDAS scores had moderate correlations with equivalent measures derived from 90-day diary data.(36) Based on physicians’ judgment of MIDAS scores on varying levels of migraine patient’s activity limitation and treatment needs, 4 grades of headache-related disability have been derived from the total MIDAS score: grade…”
BackgroundMethodInfluentialAurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,047 · cited 5×
“The MSQ has been shown to be a reliable and valid measure of HRQL among adults with CM and can differentiate the functional impact of headache across the spectrum of headache frequency as defined for EM and CM.”
MethodInfluentialDodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 994 · cited 6×
“The MSQ has been shown to be a reliable and valid measure of HRQL among adults with CM and can differentiate the functional impact of headache across the spectrum of headache frequency as defined for EM and CM.”
MethodInfluentialDiener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364677 · Cited by 960 · cited 5×
“The MSQ has been shown to be a reliable and valid measure of HRQL among adults with CM and can differentiate the functional impact of headache across the spectrum of headache frequency as defined for EM and CM.”
MethodInfluentialNew Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909 · cited 2×
“Chronic migraine (CM) is currently defined as a complication of migraine characterized by 15 headache days per month (HDPM) for at least 3 months, occurring in patients with at least 5 attacks fulfilling criteria for migraine without aura and for whom headache fulfilled criteria for pain and associated symptoms of mig…”
BackgroundMethodMigraine Diagnosis and Treatment: Results From the American Migraine Study II
Lipton, R. B., Diamond, S., Reed, M., Diamond, M. L., & Stewart, W. F. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007638.x · Cited by 726
Epidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 714
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Global prevalence of chronic migraine: A systematic review
Natoli, J., Manack, A., Dean, B., Butler, Q., Turkel, C., Stovner, L., & Lipton, R. (2010) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01941.x · Cited by 693
Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627 · cited 5×
“Although this scoring system works well for EM, a previous study found that further subdivision of grade IV allows for a clear examination of variation within CM patients.(25) Accordingly, for this study, grade IV was subdivided into grade IV-A, severe disability (scores of 21-40), and grade IV-B, very severe (scores…”
BackgroundMethodInfluentialSelf-citationPrevalence of Frequent Headache in a Population Sample
Scher, A. I., Stewart, W. F., Liberman, J., & Lipton, R. B. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3807497.x · Cited by 606
Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment
Bigal, M. E., Serrano, D., Reed, M., & Lipton, R. B. (2008) · Neurology · doi:10.1212/01.wnl.0000323925.29520.e7 · Cited by 490
The Henry Ford Hospital Headache Disability Inventory (HDI)
Jacobson, G. P., Ramadan, N. M., Aggarwal, S. K., & Newman, C. W. (1994) · Neurology · doi:10.1212/wnl.44.5.837 · Cited by 337
Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
Silberstein, S., Tfelt-Hansen, P., Dodick, D., Limmroth, V, Lipton, R., Pascual, J., Wang, S., & for the Task Force of the International Headache Society Clinical Trials Subcommittee (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01555.x · Cited by 303
Validity and Reliability of the Migraine‐Specific Quality of Life Questionnaire (MSQ Version 2.1)
Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., & Jhingran, P. (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00030.x · Cited by 299
Munakata, J., Hazard, E., Serrano, D., Klingman, D., Rupnow, M. F. T., Tierce, J., Reed, M., & Lipton, R. B. (2009) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01369.x · Cited by 299 · cited 1×
“Chronic migraine patients have been found to have reduced productivity and more missed days of work, school, housework, or family and leisure activities when compared to patients with EM(9) and are estimated to incur total costs (both direct and indirect) that are 4 times greater than those for EM patients.(11) Despit…”
BackgroundDevelopment and Validation of the Migraine‐Specific Quality of Life Questionnaire
Jhingran, P., Osterhaus, J. T., Miller, D. W., Lee, J. T., & Kirchdoerfer, L. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3804295.x · Cited by 252 · cited 8×
“We expected that lower mean MSQ scores would be observed in patients with CM than those with EM.”
MethodResultInfluentialSelf-citationBigal, M. E., Rapoport, A. M., Lipton, R. B., Tepper, S. J., & Sheftell, F. D. (2003) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2003.03068.x · Cited by 242 · cited 1×
“Studies have suggested that a higher frequency of headache attacks is associated with significantly greater levels of functional disability and reduced health-related quality of life (HRQL).(9,10) Chronic migraine patients have been found to have reduced productivity and more missed days of work, school, housework, or…”
BackgroundTepper, S. J., Dahlöf, C. G. H., Dowson, A., Newman, L., Mansbach, H., Jones, M., Pham, B., Webster, C., & Salonen, R. (2004) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.04167.x · Cited by 235
Tracing transformation: Chronic migraine classification, progression, and epidemiology
Lipton, R. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181974b19 · Cited by 184
Quality of life in chronic daily headache: A study in a general population
Guitera, V., Muñoz, P., Castillo, J., & Pascual, J. (2002) · Neurology · doi:10.1212/wnl.58.7.1062 · Cited by 161 · cited 1×
“Studies have suggested that a higher frequency of headache attacks is associated with significantly greater levels of functional disability and reduced health-related quality of life (HRQL).(9,10) Chronic migraine patients have been found to have reduced productivity and more missed days of work, school, housework, or…”
BackgroundCoeytaux, R. R., Kaufman, J. S., Chao, R. A., Mann, J. D., & DeVellis, R. F. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.05.010 · Cited by 161 · cited 1×
“The instrument has shown good reliability, construct, and convergent and face validity,(32,34) and its MID has been evaluated in a sample of patients with chronic daily headache.(35)”
BackgroundAssessment and psychological management of recurrent headache disorders.
Holroyd, K. A. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.3.656 · Cited by 109 · cited 2×
“Previous literature has summarized characteristics of both generic and disease-specific quality of life measures commonly used in headache patients, and these measures were found to vary in their specificity, the dimensions they assess, the time frame they address, as well as their psychometric properties.(15) Accordi…”
BackgroundCole, J. C., Lin, P. L., & Rupnow, M. F. T. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9217-1 · Cited by 107 · cited 5×
“We expected that lower mean MSQ scores would be observed in patients with CM than those with EM.”
MethodInfluentialImprovements in health-related quality of life with sumatriptan treatment for migraine.
Jhingran, P., Cady, R. K., Rubino, J., Miller, D., Grice, R. B., & Gutterman, D. L. (1996) · PubMed · Cited by 106
MSQ: Migraine-Specific Quality-of-Life Questionnaire
Jhingran, P. M., Thomas, S., LaVange, L. M., Miller, D. W., & Helms, R. W. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813060-00007 · Cited by 99
Psychometric Properties of the HIT‐6 Among Patients in a Headache‐Specialty Practice
Kawata, A. K., Coeytaux, R. R., DeVellis, R. F., Finkel, A. G., Mann, J. D., & Kahn, K. (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05130.x · Cited by 94
Cole, J., Lin, P., & Rupnow, M. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01852.x · Cited by 94
The Migraine Cycle: Patient Burden of Migraine During and Between Migraine Attacks
Brandes, J. L. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.01004.x · Cited by 94
Migraine Frequency and Intensity: Relationship With Disability and Psychological Factors
Magnusson, J. E., & Becker, W. J. (2003) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2003.03206.x · Cited by 88
Retinal nerve fiber layer thickness is unaffected in migraine patients
Tan, F., Akarsu, C., & Güllü, R. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00423.x · Cited by 56
Adelman, J. U., Sharfman, M. I., Johnson, R., Miller, D. W., Clements, B., Pait, D. G., Gutterman, D. L., & Batenhorst, A. S. (1996) · The American Journal of Managed Care · Cited by 53
Cohen, J., Beall, D. G., Dw, M., Beck, A. L., Pait, G., & Clements, B. (1996) · PubMed · Cited by 37
Does interferon beta help in secondary progressive MS?
Cohen, J. A., & Antel, J. P. (2004) · Neurology · doi:10.1212/01.wnl.0000147171.32178.48 · Cited by 21
Reducing the Burden of Headache
Jellinger, K. A. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00603_1.x · Cited by 4
Cited by
Ailani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
American Headache Society (2019) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13456 · Cited by 567
Tassorelli, C., Diener, H.-C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., et al. (2018) · Cephalalgia · doi:10.1177/0333102418758283 · Cited by 388
“1) is recommended to evaluate the change in quality of life related to chronic migraine (63).”
BackgroundMigraine Progression: A Systematic Review
Buse, D. C., Greisman, J. D., Baigi, K., & Lipton, R. B. (2019) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13459 · Cited by 328
Mulleners, W. M., Kim, B.-K., Láinez, M. J. A., Lanteri-Minet, M., Pozo-Rosich, P., Wang, S., Tockhorn-Heidenreich, A., Aurora, S. K., Nichols, R. M., Yunes-Medina, L., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30279-9 · Cited by 270
Metadata
- Authors
- Bagley, C. L., Rendas‐Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., Lee, J., & Kosinski, M.
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 2011-09-19
- Volume
- 52
- Issue
- 3
- Pages
- 409-421
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W2080336893
- Cited by
- 160
- References
- 48
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.